Skip to Main Content

Paper Details

Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression.
J Thorac Oncol
46
2020
7-amido-4-methylcoumarin, BAP1, BAP1 DUB, BAP1 deubiquitinase, BAP1 knockout mesothelioma cell lines, BRCA1, BRCA1-associated protein-1, BRCA1/2 mutant, BRCA1/2 mutant cancers, Cas9, Cell lines, DUB, MGMT, Mesothelioma, Mesothelioma Cells, O6-methylguanine, O6-methylguanine-DNA methyltransferase, PARP, PARPI, PARPIs, SLFN11, Schlafen, Schlafen 11, TMZ, Temozolomide, cell lines, mesothelioma, olaparib, patient, patient-derived mesothelioma cell lines, patients, poly(adenosine diphosphate-ribose), poly(adenosine diphosphate-ribose) polymerase, resistant, talazoparib, temozolomide, tumors, ubiquitin
Author NameAffiliation
Raj ChariFrederick National Laboratory for Cancer Research
Patricia FetschNational Cancer Institute, National Institutes of Health
Patricia FetschNational Cancer Institute, National Institutes of Health
Hye-Jung ChungNational Cancer Institute, National Institutes of Health
Armando C FilieNational Cancer Institute, National Institutes of Health
Armando C FilieNational Cancer Institute, National Institutes of Health
Mark RaffeldNational Cancer Institute, National Institutes of Health
Mark RaffeldNational Cancer Institute, National Institutes of Health
Yves PommierCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Yves PommierCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 10

Datasets

Release 1.2